Inflammatory cells

When exposure is repeated, the allergen binds between two adjacent IgE molecules. This causes release of inflammatory mediators (histamine, leukotrienes, chemotactic factors). These act locally and cause smooth muscle contraction, increased vascular permeability, mucous gland secretion, and infiltration of inflammatory cells (neutrophils and eosinophils). However, histamine can also be released by non-IgE-mediated mechanisms (e.g., due to exposure to certain fungi). 463... 

There are two isoforms of COX in animals COX-1 (figure a), which carries out normal, physiological production of prostaglandins, and COX-2 (figure b), which is induced by cytokines, mitogens, and endotoxins in inflammatory cells and is responsible for the production of prostaglandins in inflammation. 

Cysteinyl leukotriene is a compound synthesized from arachidonic acid in inflammatory cells that contains an amino-acid side chain. 

This is the enzyme that converts Leukotriene C4(LTC4) to Leukotriene D4 (LTD4) upon its secretion from inflammatory cells. 

The very early peak of neutrophil invasion into an inflamed area is followed several hours later by a wave of a second class of phagocytic cells, the macrophages. This biphasic pattern of inflammatory cell movement and accumulation is observed in most acute inflammatory responses. The mononuclear phagocyte in the blood is known as the monocyte and differentiates... 

In summary, recent years have seen the emergence of encouraging data for antibodies in clinical development that are directed against proinflammatory cytokines, inflammatory cells or co-stimulatory molecules. In particular, anti-TNFa therapies have set a new standard for symptom control and prevention of joint destruction in RA. 

Lymphocytes, inflammatory cells, intestinal mucosal cells, cartilage cells and bone precursor cells Inhibition of proliferation... 

Figure 17. Inflammatory cell infiltrate in a muscle biopsy from a patient with dermatomyositis note compact nature of infiltrate and perivascular location.

Muscle biopsy is usually undertaken to confirm the provisional clinical diagnosis. Because the skin lesions normally precede those in muscle, biopsies of muscle taken early may show little abnormality. Inflammatory foci may be scanty or absent and muscle fiber diameters may be normal. However typical biopsies show discrete foci of inflammatory cells, with a predominance of B-lymphocytes (see Figure 18). These cells are situated in perimysial connective tissue rather than in the en-domysium and are often also perivascular in location. Muscle fiber necrosis occurs in JDM but muscle fibers do not appear to be the primary target of the disordered immune process. Rather, it is the micro vasculature of the muscle which appears to degenerate first and muscle necrosis is preceded by capillary necrosis, detectable at the ultrastructural level. 

ADM may evolve over several years, the extent of fiber atrophy provides an important indication of the chronicity of muscle degeneration. Acute muscle necrosis and phagocytosis give some indication as to how active the disease is at the time of biopsy. In most biopsies from ADM patients, the inflammatory cell foci are perivascular and perimysial rather than endomysial and are dominated by B-lymphocytes. The ratio of T4 lymphocytes (helper cells) to T8 lymphocytes (cytotoxic) generally indicates a predominance of the former. As in JDM, this is consistent with humoral mechanisms of cell damage, and vascular involvement is also apparent in the form of capillary endothelial cell abnormalities (tubular arrays) and duplication of basal lamina. Loss of myofibrillar ATPase from the central portions of fibers is a common prelude to muscle necrosis. 

The histopathological features of PM may be radically different from those of JDM and ADM. There is little, if any, evidence of involvement of the micro vasculature and the muscle necrosis which occurs appears to be the direct result of targeting of individual muscle fibers. In the dermatomyositis syndromes, antibody-dependent humoral mechanisms are predominant and B-lymphocytes are seen to be the most abundant cell type in almost all JDM cases and a substantial proportion of ADM cases. In contrast, most muscle biopsies from PM patients show evidence of inflammation in which TS (cytotoxic) lymphocytes predominate (Figure 20). Moreover, the distribution of inflammatory cell infiltrates tends to be different. Instead of the mainly perifascicular location of lymphocytes in JDM/ADM, there... 

Tomita Y, Maeda K, Tagami H (1992) Melanocyte-stimulation properties of arachidonic acid metabolites, possible role of post-inflammatory. Cell Res 5 357-361... 

Implants in the rabbit corneas exhibited no observable inflammatory characteristics over a period of 6 weeks. Compared to other previously tested polymers, the inertness of these polyanhydrides rivals that of the biocompatible poly(hydroxyethyl methacrylate) and ethylene-vinyl acetate copolymer. Histological examination of the removed corneas also revealed the absence of inflammatory cells (21)... 

In contrast, implantation of four small pieces of poly(N-palmitoyl-hydroxyproline ester) into four rabbit corneas elicited no pathological response in three corneas and a very mild inflammatory response in one cornea. Histological examination of the corneas 4 weeks postimplantation showed no invading blood vessels or migrating inflammatory cells in the area around the implants. 

Since poly(L-tyrosine) cannot be processed into shaped devices, compressed pellets rather than solvent cast films were used as control implants. Poly(L-tyrosine) formed strikingly yellow, moderately inflamed patches that remained at the implantation site throughout the 1-year study. Contrary to soluble proteins or peptides that ar rapidly degraded by enzymes, implants of conventional poly(L-tyro-sine) were evidently nondegradable over a 1-year period. At wee 56 all poly(L-tyrosine) implants were infiltrated by a moderate n ber of inflammatory cells. 

Logan MR, Odemuyiwa SO, Moqbel R Understanding exocytosis in immune and inflammatory cells the molecular basis of mediator secretion. J Allergy Clin Immunol 2003 111 923-932. 

---